MetaCap

Tonix Pharmaceuticals Insider Trades

NASDAQ: TNXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.30+0.02 (+0.27%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
7 · $458.76K
Sales
0 · $0
Shares bought / sold
34.41K / 0
Net activity
Net buying $458,758

Tonix Pharmaceuticals insider activity

Over the last 12 months, Tonix Pharmaceuticals insiders reported 8 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $458,758 and sold $0 worth of stock, for net insider buying of $458,758. The most recent filing shows LEDERMAN SETH (Chief Executive Officer) buying 2,000 shares at $13.79 on Aug 27, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TNXP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TNXP insider transactions

Tonix Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 27, 2026LEDERMAN SETHChief Executive OfficerBuy2,000$27.58KForm 4
Aug 20, 2026BAGGER RICHARD HDirectorBuy1,000$12.60KForm 4
Jun 30, 2026SAENGER BRADLEYChief Financial Officerother1,453$15.86KForm 4
Jun 12, 2026Taylor Carolyn E.DirectorBuy1,415$14.93KForm 4
Jun 9, 2026LEDERMAN SETHChief Executive OfficerBuy5,000$58.95KForm 4
Jun 8, 2026Stillwell Richard NewcombDirectorBuy5,000$58.25KForm 4
Mar 31, 2026LEDERMAN SETHChief Executive OfficerBuy5,000$63.10KForm 4
Mar 18, 2026LEDERMAN SETHChief Executive OfficerBuy15,000$223.35KForm 4
Aug 21, 2025Taylor Carolyn E.DirectorBuy418$15.06KForm 4
Aug 20, 2025Treco JamesDirectorBuy250$9.00KForm 4
May 15, 2025LEDERMAN SETHChief Executive OfficerBuy4,000$86.20KForm 4
Feb 5, 2025MORRIS JESSICA EDGARChief Operating Officerother1—Form 4
Feb 5, 2025LEDERMAN SETHChief Executive Officerother1$0.15Form 4
Feb 5, 2025LEDERMAN SETHChief Executive Officerother0$0.73Form 4
Feb 5, 2025LEDERMAN SETHChief Executive Officerother5$17.51Form 4
Feb 5, 2025SULLIVAN GREGORY MChief Medical Officerother0$0.16Form 4
Feb 5, 2025SAENGER BRADLEYChief Financial Officerother0—Form 4
Feb 5, 2025BAGGER RICHARD HDirectorother0—Form 4
Feb 5, 2025Treco JamesDirectorother0$0.01Form 4
Feb 5, 2025Bell Margaret SmithDirectorother1$0.15Form 4
Jun 10, 2024OLUKOTUN ADEOYE YDirectorother1$1.55Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related